Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-12-17, Stock:JNJ, The news for the past five days is as follows:
2021-12-10: NEWS1: 3 Healthcare Stocks for Long-Term Dividend Growth.NEWS2: Doctor: 'We're just going to keep recycling COVID' without proper measures.NEWS3: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results.NEWS4: Here's What Investors Need to Know About Johnson & Johnson's Split.NEWS5: Is Johnson & Johnson's Upcoming Split Good or Bad News for Investors?.NEWS6: 4 Stocks That Could Be Worth $1 Trillion by 2035.NEWS7: Moderna stock drops after posting interim data for mRNA flu vaccine.NEWS8: Pfizer, BioNTech Booster Gets FDA Nod for 16- & 17-Year Olds.NEWS9: J&J's (JNJ) COVID-19 Booster Jab Gets WHO Recommendation.NEWS10: Why You Should Buy Moderna Stock at Every Dip.NEWS11: UPDATE 3-South Africa says no signal of increased Omicron severity yet.
2021-12-13: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: J&J Turned Away by U.S. Supreme Court Over Talc Cancer Suits.NEWS3: Dws Croci(r) U.s. Vip Buys SS&C Technologies Holdings Inc, Meta Platforms Inc, Johnson ....NEWS4: The Fed could tweak monetary policy based on Build Back Better passage, economist says.NEWS5: Omicron: We don't know the full effect of latest variant, doctor explains.NEWS6: Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients.NEWS7: The Zacks Analyst Blog Highlights: Pfizer, BNTX, Moderna, and J&J.NEWS8: Coronavirus: 'We need to vaccinate the unvaccinated,' doctor urges.NEWS9: UPDATE 1-U.S. Supreme Court snubs J&J's bid to avoid Mississippi talc lawsuit.NEWS10: U.S. Supreme Court snubs J&J's bid to avoid Mississippi talc lawsuit.NEWS11: U.S. Supreme Court snubs J&J's bid to avoid Mississippi talc lawsuit.NEWS12: Janssen Secures Conditional EU Marketing Authorization For Rybrevant in Lung Cancer Setting.NEWS13: U.S. Supreme Court snubs J&J's bid to avoid Mississippi talc lawsuit.NEWS14: COVID-19: U.S. coronavirus deaths near 800,000.
2021-12-14: NEWS1: U.S. study suggests COVID-19 vaccines may be ineffective against Omicron without booster.NEWS2: Pfizer early study shows vaccine is 70% effective against Omicron variant as cases rise globally.NEWS3: Merck's (MRK) HIV Studies on Islatravir Put on Clinical Hold.NEWS4: Pfizer finds COVID pill 89% effective, some hospitals drop vaccine mandates amid labor shortage.NEWS5: Pfizer Stops 70% Omicron Hospitalizations in South Africa Study.NEWS6: No Omicron deaths in J&J vaccine study in South Africa, scientist says.NEWS7: UPDATE 5-Pfizer shot less effective in South Africa after Omicron emerges - study.NEWS8: DWS CROCI(R) U.S. Fund Buys SS&C Technologies Holdings Inc, Meta Platforms Inc, Johnson ....
2021-12-15: NEWS1: Top 10 Stocks to Buy According to Legendary Value Investor Joel Greenblatt.NEWS2: Teva Pharmaceutical Finance Netherlands IV BV -- Moody's affirms Teva's Ba2 ratings; outlook revised to stable.NEWS3: Omicron variant accounts for 3% of U.S. COVID-19 cases, doctor notes that 'it's still early'.NEWS4: Unvaccinated Google employees could face termination next year.NEWS5: COVID-19: ‘We have the tools to fight Omicron,’ doctor says.NEWS6: European Medicines Committee Backs Johnson & Johnson's COVID-19 Booster Dose.NEWS7: Lilly (LLY) Phase III Study in Ulcerative Colitis Meets Goal.NEWS8: Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine.NEWS9: Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine.NEWS10: UPDATE 1-EU regulator backs J&J COVID-19 booster dose for adults.NEWS11: European Medicines Agency to recommend Johnson & Johnson COVID booster.NEWS12: Large Company Value Portfolio Buys Fresenius Medical Care AG. ....NEWS13: UPDATE 2-Sanofi, GSK say COVID-19 vaccine booster candidate give good immune response.
2021-12-16: NEWS1: Why Moderna and Pfizer Beat the Market Today.NEWS2: CDC Advisors Recommend Pfizer and Moderna’s Vaccines Over J&J’s.NEWS3: Doctor says 'We have to prepare for a surge' amid the Omicron variant's surge.NEWS4: UPDATE 5-CDC recommends Moderna, Pfizer COVID-19 vaccines over J&J's.NEWS5: Omicron is 'very transmissible,' doctor explains, and ‘people need to stay vigilant’.NEWS6: 10 Biotech Stocks in Billionaire Ray Dalio’s Portfolio.NEWS7: Unstoppable Dividend King for 2022: AbbVie or Johnson & Johnson?.NEWS8: UPDATE 1-EU watchdog okays production capacity hikes for J&J, Moderna, Pfizer vaccines.NEWS9: Airline CEOs clash with lawmakers over travel recovery, pilot shortage.NEWS10: J&J's (JNJ) COVID-19 Booster Jab Gets CHMP Recommendation.NEWS11: Teva Pharmaceutical Finance Netherlands IV BV -- Moody's affirms Teva's Ba2 ratings; outlook revised to stable.NEWS12: 10 Dividend Stocks with over 11% Yield.NEWS13: Coronavirus tally: Global cases of COVID-19 top 272 million and France restricts travel from UK over omicron variant.NEWS14: Russell Investment Funds Buys Catalent Inc, Willis Towers Watson PLC, Edison International, ....NEWS15: UPDATE 1-U.S. CDC advisers to weigh limits on J&J vaccine due to blood clot issues -Washington Post.

Answer: Decrease